Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-25-006498

Options or other derivatives

  • CEO, CFO acquired 87,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Finley John David CEO, CFO 2025-02-11 Grant or award · Stock Option (Right to Buy) +47,000 47,000 D
Finley John David CEO, CFO 2025-02-11 Grant or award · Restricted Stock Units +40,000 40,000 D
Loading xslF345X05/ownership.xml…